Schizophrenia Overview

Foundational guides to understanding schizophrenia, psychosis, and how the condition affects daily life.

Schizophrenia Overview Psychosis & Episodes Medications Side Effects Famous People with Schizophrenia Patient Experiences CBT for Psychosis Hospitalisation & Crisis Lifestyle & Wellbeing For Families & Caregivers Engineering Schizophrenia Research

Schizophrenia and anxiety disorders: a guide to common overlap

More than half of people with schizophrenia also meet criteria for at least one anxiety disorder. Treating anxiety can dramatically improve quality of life — but it's often missed.

Polypharmacy in elderly patients with schizophrenia

Older adults with schizophrenia commonly take 8 or more medications. Each one adds risk. A structured medication review is one of the most important tools in geriatric psychiatry.

Schizophrenia care in India: the District Mental Health Programme

India has one of the world's largest populations living with schizophrenia. The system relies on the District Mental Health Programme, charitable hospitals, and the irreplaceable role of family caregivers.

Childhood-onset schizophrenia: a rare and severe variant

Schizophrenia before age 13 is rare — fewer than 1 in 30,000 children — but profoundly serious. It overlaps with autism and other neurodevelopmental conditions and demands specialist care.

Positive vs negative symptoms of schizophrenia

Positive symptoms add things to a person's experience (voices, beliefs). Negative symptoms take things away (motivation, emotion, speech). Both deserve attention.

Schizophrenia self-test: what online quizzes can and can't tell you

Online schizophrenia self-tests cannot diagnose you. They can flag whether your concerns are worth bringing to a clinician, but actual diagnosis requires a comprehensive psychiatric evaluation.

IEPs and 504 plans for students with schizophrenia

An IEP and a 504 plan are different legal tools that help students with disabilities. Here's how to choose between them when schizophrenia is in the picture.

Myth: Antipsychotics turn people into zombies

The 'medication zombie' image comes from old, high-dose typical antipsychotics. Modern prescribing aims for the lowest effective dose — and most people on it do not feel flat.

Indigenous communities and schizophrenia care

Indigenous communities in the US carry a disproportionate burden of trauma, suicide, and serious mental illness — and the federal system meant to provide their care has been chronically underfunded for generations.

Mismatch negativity (MMN): a candidate biomarker for schizophrenia

Mismatch negativity is one of the most reliable biological abnormalities ever found in schizophrenia — and a window into NMDA receptor function in the living brain.

The SCID interview: what to expect

The SCID-5 is the structured interview used in research and difficult clinical cases to confirm a DSM-5 diagnosis. Here is what it looks like and how to prepare.

Schizophrenia vs schizoaffective disorder: what's the difference?

Schizoaffective disorder sits at the intersection of schizophrenia and a mood disorder (depression or bipolar). The diagnostic difference matters for treatment.

Schizophrenia myths and facts: ten things people still get wrong

Most of what people believe about schizophrenia is wrong, exaggerated, or out of date. Ten of the most persistent myths — corrected with sources, calmly.

Schizotypal vs schizoid vs schizophrenia

Three diagnoses share the 'schiz-' prefix but describe very different lives. Here is what schizotypal, schizoid, and schizophrenia actually mean.

White matter changes in schizophrenia

Diffusion MRI studies show widespread reductions in white matter integrity in schizophrenia, with the largest effects in the corpus callosum and frontotemporal tracts.

MRS (magnetic resonance spectroscopy) in schizophrenia

MR spectroscopy uses the same scanner as MRI to measure brain chemistry directly. In schizophrenia, it has produced some of the strongest non-PET evidence on glutamate, GABA, and energy metabolism.

Schizoaffective disorder vs schizophrenia: a deeper look

Schizoaffective disorder is the diagnostic middle ground between schizophrenia and primary mood disorders — and it's one of the most complicated calls in psychiatry.

Fall risk on antipsychotics in older adults

Falls are the leading cause of injury death in older adults — and antipsychotics are one of the strongest medication-related risk factors. Here's what to do.

LGBTQ+ people with schizophrenia: a deeper look at gaps in care

LGBTQ+ people with schizophrenia carry the combined weight of two heavily stigmatised identities. Recent research is finally describing the specific gaps — and what gender-affirming, trauma-informed psychiatric care looks like.

P50 sensory gating in schizophrenia

P50 sensory gating measures how the brain filters repeated sounds. People with schizophrenia gate poorly — and that finding has shaped decades of research.

Schizophrenia symptoms in adults

Adult schizophrenia symptoms fall into three groups: positive (hallucinations, delusions), negative (reduced motivation and emotion), and cognitive (attention and memory difficulties). Most people experience some from each group.

When you notice prodromal symptoms in your teen

Many parents notice the first signs of trouble months before anyone gets a diagnosis. What you do in those months matters.

Myth: Schizophrenia is purely genetic

Genetics matter in schizophrenia, but they are not destiny. Environmental, developmental, and lifestyle factors all play measurable roles.

Differential diagnosis: schizophrenia vs bipolar, drugs, autism, OCD, PTSD

Schizophrenia is one diagnosis among many that can produce overlapping symptoms. Here is how clinicians sort schizophrenia from bipolar disorder, drug-induced psychosis, autism, OCD, and PTSD.

The Trieste model: deinstitutionalisation done differently

When Franco Basaglia closed the asylum in Trieste, he replaced it with 24-hour community mental health centres. Fifty years on, the Trieste model is still studied as a benchmark for community psychiatry.

Schizophrenia and creativity: what the evidence actually shows

The 'mad genius' idea is older than psychiatry. The actual research on schizophrenia and creativity is more interesting — and more nuanced — than either the romantic or the dismissive version suggests.

Prepulse inhibition (PPI) in schizophrenia research

Prepulse inhibition tests how a small warning sound dampens the startle response. People with schizophrenia show less of this dampening — a finding that has shaped decades of research.

PET imaging in schizophrenia: dopamine and beyond

PET imaging measures neurotransmitter activity directly in the living brain. It has provided some of the strongest evidence for the dopamine hypothesis — and now points to glutamate and inflammation as well.

Schizophrenia symptoms in women: what's different

Schizophrenia in women tends to begin later than in men, often involves more mood symptoms, and is influenced by hormonal cycles. There is also a second onset peak around menopause.

The salience network in schizophrenia

The salience network helps the brain decide what deserves attention and switches between internally and externally focused modes. In schizophrenia, both functions appear disrupted.